Skip to main content
Leonard Sender, MD, Pediatric Hematology & Oncology, El Segundo, CA, Children’s Health Orange County (CHOC)

LeonardSSenderMD

Pediatric Hematology & Oncology El Segundo, CA

Medical Director Hyundai Cancer Institute CHOC Children's Hospital

Dr. Sender is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Sender's full profile

Already have an account?

Education & Training

  • Children's Hospital Los Angeles
    Children's Hospital Los AngelesFellowship, Pediatric Hematology/Oncology, 1988 - 1989
  • Children's Hospital Los Angeles
    Children's Hospital Los AngelesFellowship, Pediatric Hematology/Oncology, 1986 - 1987
  • University of California (Irvine)/Children's Hospital of Orange County
    University of California (Irvine)/Children's Hospital of Orange CountyResidency, Pediatrics, 1983 - 1986
  • University of the Witwatersrand
    University of the WitwatersrandClass of 1982

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1984 - 2024
  • American Board of Pediatrics Pediatrics

Awards, Honors, & Recognition

  • Top Doctors:LA Area Castle Connolly, 2013
  • Top Doctors:San Diego Area Castle Connolly, 2013
  • Top Doctors:Southern California Castle Connolly, 2012
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Oxford University Press Has Registered This DOI Pre-Publication  
    Leslie Appiah, Leonard Sender, Oxford University Press

Press Mentions

  • ImmunityBio Announces Authorization to Proceed with Phase 1/2/3 Randomized Trial in South Africa of Their Dual-Antigen T-cell Vaccine as a Universal Boost in Previously Vaccinated Participants Against COVID-19
    ImmunityBio Announces Authorization to Proceed with Phase 1/2/3 Randomized Trial in South Africa of Their Dual-Antigen T-cell Vaccine as a Universal Boost in Previously Vaccinated Participants Against COVID-19July 14th, 2021
  • ImmunityBio Expands Trials of T-cell-Based COVID-19 Vaccine Candidate as a ‘Universal Boost’ in Vaccinated Subjects and Receives Approval to Test Intranasal Spray in South Africa
    ImmunityBio Expands Trials of T-cell-Based COVID-19 Vaccine Candidate as a ‘Universal Boost’ in Vaccinated Subjects and Receives Approval to Test Intranasal Spray in South AfricaMay 25th, 2021
  • NantKwest Names Pediatric VP
    NantKwest Names Pediatric VPMay 16th, 2017
  • Join now to see all

Hospital Affiliations